| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Giordano Christopher Thomas | CEO, Director | 101 GLEN LENNOX DRIVE, SUITE 300, CHAPEL HILL | /s/ S. Halle Vakani, as Attorney-in-Fact | 20 Nov 2025 | 0001871714 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TENX | Common Stock | Purchase | $12,500 | +1,612 | $7.75 | 1,612 | 18 Nov 2025 | Direct | F1 | |
| transaction | TENX | Common Stock | Purchase | $3,417 | +455 | +28% | $7.51 | 2,067 | 19 Nov 2025 | Direct | F2 |
| transaction | TENX | Common Stock | Purchase | $4,083 | +538 | +26% | $7.59 | 2,605 | 20 Nov 2025 | Direct | F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | TENX | Stock Option (right to buy) | 157 | 18 Nov 2025 | Common Stock | 157 | $3152.00 | Direct | F4 | |||||
| holding | TENX | Stock Option (right to buy) | 125 | 18 Nov 2025 | Common Stock | 125 | $992.00 | Direct | F5 | |||||
| holding | TENX | Stock Option (right to buy) | 437 | 18 Nov 2025 | Common Stock | 437 | $3.55 | Direct | F6 | |||||
| holding | TENX | Stock Option (right to buy) | 1,250,000 | 18 Nov 2025 | Common Stock | 1,250,000 | $5.94 | Direct | ||||||
| holding | TENX | Stock Option (right to buy) | 1,400,000 | 18 Nov 2025 | Common Stock | 1,400,000 | $5.89 | Direct | F7 |
| Id | Content |
|---|---|
| F1 | This transaction was executed in multiple trades at prices ranging from $7.47 to $7.68. The price reported in Column 4 is a weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. |
| F2 | This transaction was executed in multiple trades at prices ranging from $7.35 to $7.62. The price reported in Column 4 is a weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. |
| F3 | This transaction was executed in multiple trades at prices ranging from $7.54 to $7.73. The price reported in Column 4 is a weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. |
| F4 | The options vested and became exercisable as follows: 25% of the underlying shares of common stock vested and became exercisable on each of July 6, 2022, July 6, 2023, July 6, 2024, and July 6, 2025, subject to the Reporting Person's continued employment. |
| F5 | The options vest and become exercisable as follows: 25% of the underlying shares of common stock vest and become exercisable on each of June 9, 2023, June 9, 2024, June 9, 2025, and June 9, 2026, subject to the Reporting Person's continued employment. |
| F6 | The options vest and become exercisable as follows: 25% of the underlying shares of common stock vest and become exercisable on each of May 17, 2025, May 17, 2026, May 17, 2027, and May 17, 2028, subject to the Reporting Person's continued employment. |
| F7 | The options vest and become exercisable as follows: 25% of the underlying shares of common stock vest and become exercisable on May 16, 2026, and thereafter 1/36th of the remaining shares will vest on the last day of each following month for a period of 36 months, subject to the Reporting Person's continued employment. |